We present a case of a 61-year-old woman with an atypical non-arteritic anterior ischemic optic neuropathy (NA-AION) as a unique manifestation of COVID-19. Furthermore, the patient worsened after Pfizer-BioNTech COVID-19 vaccine administration. Our findings suggest that NA-AION could result from microangiopathic/thrombotic events that may occur during SARS-CoV-2 infection and/or vaccination against COVID-19. This report sheds light on possible ophthalmologic complications of COVID-19.
RhoJDrydenSCMcGuffeyCD, et al. A Case of Non-Arteritic Anterior Ischemic Optic Neuropathy with COVID-19. Cureus2020; 12: e11950. 2021/01/12. DOI: 10.7759/cureus.11950.
3.
MoschettaLFasolinoGKuijpersRW. Non-arteritic anterior ischaemic optic neuropathy sequential to SARS-CoV-2 virus pneumonia: preventable by endothelial protection?BMJ case reports2021; 14: e240542. DOI: 10.1136/bcr-2020-240542.
4.
SavastanoACrincoliESavastanoMC, et al. Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J Clin Med2020; 9. 2020/09/12. DOI: 10.3390/jcm9092895.
5.
CinesDBBusselJB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. The New England journal of medicine2021; 384: 2254–2256. 2021/04/16. DOI: 10.1056/NEJMe2106315.
